New perspectives on PKCθ, a member of the novel subfamily of protein kinase C

Stem Cells

Volumn 16, Issue 3, 1998, Pages 178-192

  Meller, Nahum ^a   Altman, Amnon ^b   Isakov, Noah ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Cell signaling; Isoenzymes; PKC; Protein kinase; T cell activation

Indexed keywords

PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; T LYMPHOCYTE RECEPTOR; ISOENZYME; LYMPHOCYTE ANTIGEN RECEPTOR; NEF PROTEIN; PRKCQ PROTEIN, HUMAN;

ANTIGEN PRESENTING CELL; CELLULAR DISTRIBUTION; HUMAN; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIBODY SPECIFICITY; B LYMPHOCYTE; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; HEMATOPOIESIS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; INSULIN RESISTANCE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; GENE PRODUCTS, NEF; HEMATOPOIESIS; HIV; HUMANS; INSULIN RESISTANCE; ISOENZYMES; LYMPHOCYTE ACTIVATION; MUSCLE, SKELETAL; ORGAN SPECIFICITY; PROTEIN KINASE C; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031595974     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.160178     Document Type: Review

References (167)

1. Baier G, Telford D, Giampa L et al. Molecular cloning and characterization of PKCθ, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 1993;268:4997-5004.
2. Osada S, Mizuno K, Saido TC et al. A new member of the protein kinase C family, nPKCθ, predominantly expressed in skeletal muscle. Mol Cell Biol 1992:12:3930-3938.
3. Chang JD, Xu Y, Raychowdhury MK et al. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets. J Biol Chem 1993;268:14208-14214.
4. Erdel M, Baier Bitterlich G, Duba C et al. Mapping of the human protein kinase C-θ (PRKCQ) gene locus to the short arm of chromosome 10 (10p15) by FISH. Genomics 1995;25:595-597.
5. Parker PJ, Coussens L, Totty N et al. The complete primary structure of protein kinase C - the major phorbol ester receptor. Science 1986;233:853-859.
6. Coussens L, Parker PJ, Rhee L et al. Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science 1986;233:859-866.
7. Ono Y, Kurokawa T, Fujii T et al. Two types of complementary DNAs of rat brain protein kinase C. Heterogeneity determined by alternative splicing. FEBS Lett 1986;206:347-352.
8. Knopf JL, Lee MH, Sultzman LA et al. Cloning and expression of multiple protein kinase C cDNAs. Cell 1986;46:491-502.
9. Ohno S, Kawasaki H, Imajoh S et al. Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature 1987;325:161-166.
10. Kubo K, Ohno S, Suzuki K. Primary structures of human protein kinase C βI and βII differ only in their C-terminal sequences. FEBS Lett 1987;223:138-142.
11. Coussens L, Rhee L, Parker PJ et al. Alternative splicing increases the diversity of the human protein kinase C family. DNA 1987;6:389-394.
12. Ono Y, Fujii T, Igarashi K et al. Nucleotide sequences of cDNAs for a and γ subspecies of rat brain protein kinase C. Nucleic Acids Res 1988;16:5199-5200.
13. Rose-John S, Dietrich A, Marks F. Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblasts. Gene 1988;74:465-471.
14. Ohno S, Kawasaki H, Konno Y et al. A fourth type of rabbit protein kinase C. Biochemistry 1988;27:2083-2087.
15. Finkenzeller G, Marme D, Hug H. Sequence of human protein kinase C α. Nucleic Acids Res 1990;18:2183.
16. Bowers BJ, Parham CL, Sikela JM et al. Isolation and sequence of a mouse brain cDNA coding for protein kinase C-γisozyme. Gene 1993;123:263-265.
17. Ono Y, Fujii T, Ogita K et al. Identification of three additional members of rat protein kinase C family: δ-, ε-and ζ-subspecies. FEBS Lett 1987;226:125-128.
18. Ono Y, Fujii T, Ogita K et al. The structure, expression, and properties of additional members of the protein kinase C family. J Biol Chem 1988;263:6927-6932.
19. Ohno S, Akita Y, Konno Y et al. A novel phorbol ester receptor/protein kinase, nPKC, distantly related to the protein kinase C family. Cell 1988;53:731-741.
20. Osada S, Mizuno K, Saido TC et al. A phorbol ester receptor/protein kinase, nPKC η, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem 1990;265:22434-22440.
21. Mischak H, Bodenteich A, Kolch W et al. Mouse protein kinase C-δ, the major isoform expressed in mouse hemopoietic cells: sequence of the cDNA, expression patterns, and characterization of the protein. Biochemistry 1991;30:7925-7931.
22. Mizuno K, Kubo K, Saido TC et al. Structure and properties of a ubiquitously expressed protein kinase C, nPKC δ. Eur J Biochem 1991;202:931-940.
23. Bacher N, Zisman Y, Berent E et al. Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart. Mol Cell Biol 1991;11:126-133.
24. Basta P, Strickland MB, Holmes W et al. Sequence and expression of human protein kinase C-ε. Biochim Biophys Acta 1992;1132:154-160.
25. Johannes FJ, Prestle J, Eis S et al. PKC μ is a novel, atypical member of the protein kinase C family. J Biol Chem 1994;269:6140-6148.
26. Ono Y, Fujii T, Ogita K et al. Protein kinase C ζ subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci USA 1989;86:3099-3103.
27. Goodnight J, Kazanietz MG. Blumberg PM et al. The cDNA sequence, expression pattern and protein characteristics of mouse protein kinase C-ζ. Gene 1992;122:305-311.
28. Kochs G, Hummel R, Meyer D et al. Activation and substrate specificity of the human protein kinase C α and ζ isoenzymes. Eur J Biochem 1993;216:597-606.
29. Selbie LA, Schmitz-Peiffer C, Sheng Y et al. Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem 1993;268:24296-24302.
30. Stabel S, Parker PJ. Protein kinase C. Pharmacol Ther 1991;51:71-95.
31. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496.
32. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
33. Newton A. Protein kinase C; structure, function, and regulation. J Biol Chem 1995;270:28495-28498.
34. Keranen LM, Dutil EM, Newton AC. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr Biol 1995;12:1394-1403.
35. Tsutakawa SE, Medzihradszky KF, Flint AJ et al. Determination of in vivo phosphorylation sites in protein kinase C. J Biol Chem 1995;270:26807-26812.
36. Borner C, Filipuzzi I, Wartmann M et al. Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J Biol Chem 1989;264:13902-13909.
37. Orr JW, Keranen LM, Newton AC. Reversible exposure of the pseudosubstrate domain of protein kinase C by phosphatidylserine and diacylglycerol. J Biol Chem 1992;267:15263-15266.
38. Orr JW, Newton AC. Intrapeptide regulation of protein kinase C. J Biol Chem 1994;269:8383-8387.
39. Mochly Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 1995;268:247-251.
40. Newton A. Protein kinase C: ports of anchor in the cell. Curr Biol 1996;6:806-809.
41. Baier G, Baier-Bitterlich G, Melier N et al. Expression and biochemical characterization of human protein kinase C θ. Eur J Biochem 1994;225:195-203.
42. Donnelly R, Reed MJ, Azhar S et al. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKCθ, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 1994;135:2369-2374.
43. Mischak H, Goodnight J, Henderson DW et al. Unique expression pattern of protein kinase C-θ: high mRNA levels in normal mouse testes and in T-lymphocytic cells and neoplasms. FEBS Lett 1993;326:51-55.
44. Hilgenberg L, Miles K. Developmental regulation of a protein kinase C isoform localized in the neuromuscular junction. J Cell Sci 1995;108:51-61.
45. Erdbrugger W, Keffel J, Knocks M et al. Protein kinase C isoenzymes in rat and human cardiovascular tissues. Br J Pharmacol 1997;120:177-186.
46. Greenberg SM, Rosenthal DS, Greeley TA et al. Characterization of a new megakaryocytic cell line: the Dami cell. Blood 1988;72:1968-1977.
47. Ogura M, Morishima Y, Okumura M et al. Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters. Blood 1988;72:49-60.
48. Nagata KI, Okano Y, Nozawa Y. Protein kinase C isozymes in human megakaryoblastic leukemia cell line, MEG-01: possible involvement of the isozymes in the differentiation process of MEG-01 cells. Br J Haematol 1996;93:762-771.
49. Ballen KK, Ritchie AJ, Murphy C et al. Expression and activation of protein kinase C isoforms in a human megakaryocytic cell line. Exp Hematol 1996;24:1501-1508.
50. Wang F, Naik UP, Ehrlich YH et al. Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets. Biochem J 1995;311:401-406.
51. Wang F, Naik UP, Ehrlich YH et al. A new protein kinase C, nPKCη, and nPKCθ are expressed in human platelets: involvement of nPKCη and nPKCθ in signal transduction stimulated by PAF. Biochem Biophys Res Commun 1993;191:240-246.
52. Zauli G, Bassini A, Catani L et al. PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. Br J Haematol 1996;92:530-536.
53. Rosson D, O'Brien TG. Expression and modulation of protein kinase C isoforms in differentiation-competent and differentiation-resistant erythroleukemic cells. Biochem Biophys Res Commun 1995;210:90-97.
54. Alitalo R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leuk Res 1990;14:501-514.
55. Berry DM, Antochi R, Bhatia M et al. 1,25-Dihydroxyvitamin D3 stimulates expression and translocation of protein kinase Cα and Cδ via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells. J Biol Chem 1996;271:16090-16096.
56. Harris P, Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leuk Biol 1985;37:407-422.
57. Auwerx J. The human leukemia cell line. THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia 1991;47:22-31.
58. Okabe-Kado J, Honma Y, Hayashi M et al. Induction of differentiation of mouse myeloid leukemia M1 cells by serum of patients with chronic myeloid leukemia. Jpn J Cancer Res 1988;79:1318-1326.
59. Tsutsumi A, Kubo M, Fujii H et al. Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells. J Immunol 1993;150:1746-1754.
60. Monks CRF, Kupfer H, Tamir I et al. Selective modulation of protein kinase C-θ during T-cell activation. Nature 1997;385:83-86.
61. Kupfer A, Singer SJ. The specific interaction of helper T cells and antigen-presenting B cells. IV. Membrane and cytoskeletal reorganizations in the bound T cell as a function of antigen dose. J Exp Med 1989;170:1697-1713.
62. Isakov N. The role of immunoreceptor tyrosine-based activation motif (ITAM) in signal transduction from antigen and Fc receptors. Adv Immunol 1998 (in press).
63. Sloan-Lancaster J, Shaw AS, Rothbard JB et al. Partial T cell signaling: altered phospho-ζ and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell 1994;79:913-922.
64. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993;363:156-159.
65. Madrenas J, Wange RL, Wang JL et al. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 1995;267:515-518.
66. Isakov N, Bleackley RC, Shaw J et al. The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells. J Immunol 1985;135:2343-2350.
67. Isakov N, Bleackley RC, Shaw J et al. Teleocidin and phorbol ester tumor promoters exert similar mitogenic effects on human lymphocytes. Biochem Biophys Res Commun 1985;130:724-731.
68. Ullman KS, Northrop JP, Verweij CL et al. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990;8:421-452.
69. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science 1989;243:355-361.
70. Angel P, Karin M. The role of Jun. Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-157.
71. Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr Opin Immunol 1995;7:333-342.
72. Jain J, McCaffrey PG, Valge-Archer VE et al. Nuclear factor of activated T cells contains Fos and Jun. Nature 1992;356:801-804.
73. Northrop JP, Ullman KS, Crabtree GR. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 1993;268:2917-2923.
74. Jain J, Valge-Archer VE, Sinskey AJ et al. The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter. J Exp Med 1992;175:853-862.
75. Ioannides CG, Freedman RS, Liskamp RM et al. Inhibition of IL-2 receptor induction and IL-2 production in Jurkat cells by a novel peptide inhibitor of PKC. Cell Immunol 1990;131:242-248.
76. Kvanta A, Kontny E, Jondal M et al. Mitogen stimulation of T-cells increases c-Fos and c-Jun protein levels. AP-1 binding and AP-1 transcriptional activity. Cell Signaling 1992;4:275-282.
77. Baier-Bitterlich G, Überall F, Bauer B et al. Protein kinase C-θ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol 1996;16:1842-1850.
78. Meller N, Liu YC, Collins TL et al. Direct interaction between protein kinase C θ (PKCθ) and 14-3-3τ in T cells: 14-3-3 overexpression results in inhibition of PKC θ translocation and function. Mol Cell Biol 1996;16:5782-5791.
79. Hirano M, Hirai S, Mizuno K et al. A protein kinase C isozyme, nPKCε, is involved in the activation of NF-κB by 12-O-tetradecanoylphorbol-13-acetate (TPA) in rat 3Y1 fibroblasts. Biochem Biophys Res Commun 1995;206:429-436.
80. Hirai S, Izumi Y, Higa K et al. Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. EMBO J 1994;13:2331-2340.
81. Ghaffari-Tabrizi N, Bauer B, Baier-Bitterlich G et al. PKCθ, a selective upstream regulator of JNK/SAPK in Jurkat T-cells. J Biol Chem 1998 (in press).
82. Aitken A. 14-3-3 and its possible role in coordinating multiple signaling pathways. Trends Cell Biol 1996;6:341-347.
83. Muslin AJ, Tanner JW, Allen PM et al. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996;84:889-897.
84. Yaffe MB, Rittinger K, Volinia S et al. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 1997;91:961-971.
85. Robinson K, Jones D, Howell S et al. Expression and characterization of maize ZBP14, a member of a new family of zinc-binding proteins. Biochem J 1995;307:267-272.
86. Toker A, Ellis CA, Sellers LA et al. Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 protein. Eur J Biochem 1990;191:421-429.
87. Toker A, Sellers LA, Amess B et al. Multiple isoforms of a protein kinase C inhibitor (KCIP-1/14-3-3) from sheep brain. Amino acid sequence of phosphorylated forms. Eur J Biochem 1992;206:453-461.
88. Aitken A, Howell S, Jones D et al. Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol Cell Biochem 1995;150:41-49.
89. Acs P, Szallasi Z, Kazanietz MG et al. Differential activation of PKC isozymes by 14-3-3 ζ protein. Biochem Biophys Res Commun 1995;216:103-109.
90. Dellambra E, Patrone M, Sparatore B et al. Stratifin, a keratinocyte specific 14-3-3 protein, harbors a pleckstrin homology (PH) domain and enhances protein kinase C activity. J Cell Sci 1995;108:3569-3579.
91. Isobe T, Hiyane Y, Ichimura T et al. Activation of protein kinase C by the 14-3-3 proteins homologous with Exol protein that stimulates calcium-dependent exocytosis. FEBS Lett 1992;308:121-124.
92. Tanji M, Horwitz R, Rosenfeld G et al. Activation of protein kinase C by purified bovine brain 14-3-3: comparison with tyrosine hydroxylase activation. J Neurochem 1994;63:1908-1916.
93. Chen F, Wagner PD. 14-3-3 proteins bind to histone and affect both histone phosphorylation and dephosphorylation. FEBS Lett 1994;347:128-132.
94. Morgan A, Burgoyne RD. Interaction between protein kinase C and Exol (14-3-3 protein) and its relevance to exocytosis in permeabilized adrenal chromaffin cells. Biochem J 1992;286:807-811.
95. Peng CY, Graves PR, Thoma RS et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997;277:1501-1505.
96. Zha J, Harada H, Yang E et al. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996;87:619-628.
97. Weinhold KJ, Lyerly HK, Stanley SD et al. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol 1989;142:3091-3097.
98. Silberman SL, Goldman SJ, Mitchell DB et al. The interaction of CD4 with HTV-1 gp120. Semin Immunol 1991;3:187-192.
99. Liegler TJ, Stiles DP. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J Acquir Immune Defic Syndr 1994;7:340-348.
100. Theodore AC, Kornfeld H, Wallace RP et al. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. J Acquir Immune Defic Syndr 1994;7:899-907.
101. Geleziunas R, Miller MD, Greene WC. Unraveling the function of HIV type 1 Nef. AIDS Res Hum Retroviruses 1996;12:1579-1582.
102. Garcia JV, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991;350:508-511.
103. Brady HJ, Pennington DJ, Miles CG et al. CD4 cell surface downregulation in HTV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO J 1993;12:4923-4932.
104. Mariani R, Skowronski J. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc Natl Acad Sci USA 1993;90:5549-5553.
105. Aiken C, Konner J, Landau NR et al. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membraneproximal CD4 cytoplasmic domain. Cell 1994;76:853-864.
106. Greenway AL, McPhee DA, Grgacic E et al. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology 1994;198:245-256.
107. Luria S, Chambers I, Berg P. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci USA 1991;88:5326-5330.
108. Bandres JC, Ratner L. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J Virol 1994;68:3243-3249.
109. Niederman TM, Garcia JV, Hastings WR et al. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells. J Virol 1992;66:6213-6219.
110. Niederman TM, Hastings WR, Luria S et al. HTV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 1993;194:338-344.
111. Sawai ET, Baur A, Struble H et al. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc Natl Acad Sci USA 1994;91:1539-1543.
112. Sawai ET, Baur AS, Peterlin BM et al. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem 1995;270:15307-15314.
113. Bodeus M, Marie-Cardine A, Bougeret C et al. In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. J Gen Virol 1995;76:1337-1344.
114. Luo T, Garcia JV. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J Virol 1996;70:6493-6496.
115. Lu X, Wu X, Plemenitas A et al. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr Biol 1996;6:1677-1684.
116. Lang SM, Iafrate AJ, Stahl HC et al. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat Med 1997;3:860-865.
117. Collins KL, Chen BK, Kalams SA et al. HIV-1 Nef protein protects infected primary cells aganist killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.
118. Smith BL, Krushelnycky BW, Mochly-Rosen D et al. The HIV Nef protein associates with protein kinase C θ. J Biol Chem 1996;271:16753-16757.
119. Hilgenberg L, Yearwood S, Milstein S et al. Neural influence on protein kinase C isoform expression in skeletal muscle. J Neurosci 1996;16:4994-5003.
120. Ishizuka T, Cooper DR, Hernandez H et al. Effects of insulin on diacylglycerol-protein kinase C signaling in rat diaphragm and soleus muscles and relationship to glucose transport. Diabetes 1990;39:181-190.
121. Yu B, Standaert M, Arnold T et al. Effects of insulin on diacylglycerol/protein kinase C signaling and glucose transport in rat skeletal muscles in vivo and in vitro. Endocrinology 1992;130:3345-3355.
122. Yamada K, Avignon A, Standaert ML et al. Effects of insulin on the translocation of protein kinase C-θ and other protein kinase C isoforms in rat skeletal muscles. Biochem J 1995;308:177-180.
123. James DE, Jenkins AB, Kraegen EW. Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol 1985;248:E567-E574.
124. Azhar S, Butte JC, Santos RF et al. Characterization of insulin receptor kinase activity and autophosphorylation in different skeletal muscle types. Am J Physiol 1991;260:E1-E7.
125. Avignon A, Standaert ML, Yamada K et al. Insulin increases mRNA levels of protein kinase C-α and -β in rat adipocytes and protein kinase C-α, -β and -θ in rat skeletal muscle. Biochem J 1995;308:181-187.
126. Schmitz-Peiffer C, Browne CL, Oakes ND et al. Alterations in the expression and cellular localization of protein kinase C isozymes ε and θ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997;46:169-178.
127. Bollag GE, Roth RA, Beaudoin J et al. Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA 1986;83:5822-5824.
128. Karasik A, Rothenberg PL, Yamada K et al. Increased protein kinase activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. J Biol Chem 1990;265:10226-10231.
129. Danielsen AG, Liu F, Hosomi Y et al. Activation of protein kinase C α inhibits signaling by members of the insulin receptor family. J Biol Chem 1995;270:21600-21605.
130. + and phospholipid-activated protein kinase C. J Biol Chem 1984;259:8743-8747.
131. Blackmore PF, Strickland WG, Bocckino SB et al. Phosphorylation of glycogen synthase by protein kinase C. Biochem J 1986;237:235-242.
132. Presta M, Tiberio L, Rusnati M et al. Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. Cell Regul 1991;2:719-726.
133. Kent KC, Mii S, Harrington EO et al. Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation. Circ Res 1995;77:231-238.
134. Tang S, Morgan KG, Parker C et al. Requirement for protein kinase C θ for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells. J Biol Chem 1997;272:28704-28711.
135. Tsukita S, Oishi K, Sato N et al. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994;126:391-401.
136. Pietromonaco SF, Simons PC, Altman A et al. Protein kinase C-θ phosphorylation of moesin in the actin-binding sequence. J Biol Chem 1998 (in press).
137. Nakamura F, Amieva MR, Furthmayr H. Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. J Biol Chem 1995;270:31377-31385.
138. Chan AC, Iwashima M, Turck CW et al. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR C chain. Cell 1992;71:649-662.
139. Zhang W, Sloan-Lancaster J, Kitchen J et al. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998;92:83-92.
140. Wilbom TW, Schafer JA. Differential expression of PKC isoforms in fresh and cultured rabbit CCD. Am J Physiol 1996;270:F766-F775.
141. Avignon A, Yamada K, Zhou X et al. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis. Diabetes 1996;45:1396-1404.
142. + sensitization of myosin light chain phosphorylation in smooth muscle. Biochem J 1996;318:469-475.
143. Donnelly R, Yang K, Omary MB et al. Expression of multiple isoenzymes of protein kinase C in airway smooth muscle. Am J Respir Cell Mol Biol 1995;13:253-256.
144. + mobilization in canine cultured tracheal smooth muscle cells by phorbol ester. Br J Pharmacol 1997;121:853-860.
145. Webb BL, Lindsay MA, Seybold J et al. Identification of the protein kinase C isoenzymes in human lung and airways smooth muscle at the protein and mRNA level. Biochem Pharmacol 1997;54:199-205.
146. Togashi H, Hirshman CA, Emala CW. Qualitative immunoblot analysis of PKC isoforms expressed in airway smooth muscle. Am J Physiol 1997;272:L603-L607.
147. Pfeilschifter J, Huwiler A. Regulatory functions of protein kinase C isoenzymes in purinoceptor signaling in mesangial cells. J Auton Pharmacol 1996;16:315-318.
148. Birkenfeld HP, Mclntyre BS, Briski KP et al. Protein kinase C isoenzyme expression in normal mouse mammary epithelial cells grown in primary culture. Proc Soc Exp Biol Med 1996;213:65-70.
149. Chen CC, Chen WC. ATP-evoked inositol phosphates formation through activation of P2U purinergic receptors in cultured astrocytes: regulation by PKC subtypes α, δ, and θ. Glia 1996;17:63-71.
150. Lin WW, Wang CW, Chuang DM. Effects of depolarization and NMDA antagonists on the role survival of cerebellar granule cells: a pivotal role for protein kinase C isoforms. J Neurochem 1997;68:2577-2586.
151. Eicheler W, Huth A, Happle R et al. Phorbol-myristate-acetate, but not interleukin-1 β or insulin-like growth factor-I, regulates protein kinase C isoenzymes in human dermal papilla cells. Acta Derm Venereol 1997;77:361-364.
152. Sanders JL, Stern PH. Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts. J Bone Miner Res 1996;11:1862-1872.
153. Yamamura S, Nelson PR, Kent KC. Role of protein kinase C in attachment, spreading, and migration of human endothelial cells. J Surg Res 1996;63:349-354.
154. Patel V, Brown C, Boarder MR. Protein kinase C isoforms in bovine aortic endothelial cells: role in regulation of P2Y-and P2U-purinoceptor-stimulated prostacyclin release. Br J Pharmacol 1996;118:123-130.
155. Traub O, Monia BP, Dean NM et al. PKC-ε is required for mechano-sensitive activation of ERK1/2 in endothelial cells. J Biol Chem 1997;272:31251-31257.
156. Davies R, Budworth J, Riley J et al. Regulation of P-glycoprotein 1 and 2 gene expression and protein activity in two MCF-7/Dox cell line subclones. Br J Cancer 1996;73:307-315.
157. Budworth J, Cant TW, Gescher A. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revenant MCF-7/Adr breast carcinoma cells. Br J Cancer 1997;75:1330-1335.
158. Hrzenjak M, Shain SA. Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway. Cell Growth Differ 1995;6:1129-1142.
159. Thorp KM, Verschueren H, De Baetselier P et al. Protein kinase C isotype expression and regulation of lymphoid cell motility. Immunology 1996;87:434-438.
160. Chen CC, Wu ML. Protein kinase C isoform δ is involved in the stimulation of the Na(+)-H+ exchanger in C6 glioma cells. Mol Pharmacol 1995;48:995-1003.
161. Wooten MW, Zhou G, Wooten MC et al. Transport of protein kinase C isoforms to the nucleus of PC 12 cells by nerve growth factor: association of atypical ζ-PKC with the nuclear matrix. J Neurosci Res 1997;49:393-403.
162. Battaini F, Pascale A, Lucchi L et al. Expression and regulation of calcium-independent protein kinase C in NG 108-15 cell differentiation. Biochem Biophys Res Commun 1994;203:1423-1431.
163. Chen CC, Chen WC. P2Y receptor linked to phospholipase C: stimulation of neuro 2A cells by UTP and ATP and possible regulation by protein kinase C subtype ε. J Neurochem 1997;69:1409-1416.
164. McGowan K, De Vente J, Carey JO et al. Protein kinase C isoform expression during the differentiation of 3T3-L1 preadipocytes: loss of protein kinase C-α isoform correlates with loss of phorbol 12-myristate 13-acetate activation of nuclear factor kappa B and acquisition of the adipocyte phenotype. J Cell Physiol 1996;167:113-120.
165. Keogh BP, Tresini M, Cristofalo VJ et al. Effects of cellular aging on the induction of c-fos by antioxidant treatments. Mech Ageing Dev 1996;86:151-160.
166. Jones T, Courage C, Hubbard A et al. Cellular relocalisation of protein kinase C-θ caused by staurosporine and some of its analogues. Biochem Pharmacol 1997;53:1413-1418.
167. Courage C, Bradder SM, Jones T et al. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine. Int J Cancer 1997;73:763-768.